Cargando…
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disease associated with a break in self-tolerance reflected by a production of antinuclear autoantibodies. Since autoantibody production can be activated via nucleic acid Toll-like receptor 9 (TLR9), the respective pathway has been im...
Autores principales: | Sieber, Julia, Daridon, Capucine, Fleischer, Sarah J, Fleischer, Vanessa, Hiepe, Falk, Alexander, Tobias, Heine, Guido, Burmester, Gerd R, Fillatreau, Simon, Dörner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247768/ https://www.ncbi.nlm.nih.gov/pubmed/25385499 http://dx.doi.org/10.1186/s13075-014-0477-1 |
Ejemplares similares
-
Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
por: Fleischer, Vanessa, et al.
Publicado: (2015) -
Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
por: Smith, Michael F, et al.
Publicado: (2009) -
Toll-like receptor signalling in B cells during systemic lupus erythematosus
por: Fillatreau, Simon, et al.
Publicado: (2020) -
The cytokine memory of SmD1(83-119)-autoantigen-specific Th cells of systemic lupus erythematosus patients
por: Langer, S, et al.
Publicado: (2005) -
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
por: Daridon, Capucine, et al.
Publicado: (2010)